Podiatrist · Brooklyn, NY
NPI
1295818706
Since 2006
Specialty
Podiatrist
Code 213E00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
999 Blake Ave
Brooklyn, NY, 11208
Phone (718) 277-8303
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$810K
2,062 prescriptions
Company payments, 2025
$238
From 1 companies
Medicare prescription drug claims, 2024
In 2024, the drug Karl Cirincione prescribed most often to Medicare patients was Doxepin Hcl, with 316 prescriptions and refills. In total Karl Cirincione wrote 2,062 Medicare prescriptions that cost $810K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Doxepin Hcl Generic | 316 | 340 | 124 | $263K |
| Clobetasol Propionate Generic | 305 | 460 | 88 | $124K |
| Ammonium Lactate Generic | 261 | 279 | 83 | $4,665 |
| Caspofungin Acetate Generic | 190 | 190 | 57 | $49K |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 144 | 146 | 52 | $53K |
| Diflorasone Diacetate Generic | 134 | 145 | 35 | $90K |
| Betamethasone Dipropionate Generic | 122 | 165 | 38 | $21K |
| Fluocinonide Generic | 90 | 105 | 47 | $34K |
| Budesonide Er Budesonide | 85 | 85 | 22 | $70K |
| Gabapentin Generic | 67 | 79 | 22 | $499 |
| Meloxicam Generic | 52 | 52 | 34 | $51.24 |
| Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip | 51 | 51 | 16 | $805 |
| Clotrimazole Generic | 40 | 40 | 12 | $1,210 |
| Naproxen Sodium Er Naproxen Sodium | 35 | 35 | 18 | $33K |
| Terbinafine Hcl Generic | 34 | 34 | 19 | $237 |
Brand drugs: 365 claims; generic drugs: 1,697 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Karl Cirincione $238 ($238 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $238.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 2 | $238 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.